| 5th May 2023 4:30 pm |
RNS |
Total Voting Rights |
| 4th May 2023 5:02 pm |
RNS |
Director/PDMR Shareholding |
| 4th May 2023 12:15 pm |
RNS |
Director/PDMR Shareholding |
| 2nd May 2023 3:52 pm |
RNS |
Director/PDMR Shareholding |
| 27th Apr 2023 7:00 am |
EQS |
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune |
| 25th Apr 2023 7:03 am |
EQS |
Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM |
| 19th Apr 2023 1:30 pm |
EQS |
Full Year results now to be released on 25 April 2023 |
| 17th Apr 2023 7:00 am |
EQS |
Unaudited NAV for March 2023 |
| 14th Apr 2023 12:00 pm |
EQS |
Notice of Results and Investor Presentation |
| 28th Mar 2023 7:00 am |
EQS |
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement |
| 16th Mar 2023 7:01 am |
EQS |
Unaudited NAV for February 2023 |
| 14th Feb 2023 6:19 pm |
EQS |
Portfolio company Disc Medicine announces $62.5 million financing |
| 6th Feb 2023 6:00 pm |
EQS |
Director/PDMR Shareholding |
| 6th Feb 2023 5:00 pm |
EQS |
Director/PDMR Shareholding |
| 6th Feb 2023 8:00 am |
EQS |
Unaudited NAV for January 2023 |
| 6th Feb 2023 7:00 am |
EQS |
Unaudited NAV for January 2023 |
| 30th Jan 2023 8:00 am |
EQS |
Unaudited NAV for December 2022 |
| 30th Jan 2023 7:00 am |
EQS |
Unaudited NAV for December 2022 |
| 26th Jan 2023 8:00 am |
EQS |
Board Change |
| 26th Jan 2023 7:00 am |
EQS |
Board Change |
| 5th Jan 2023 5:20 pm |
EQS |
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma |
| 5th Jan 2023 4:21 pm |
EQS |
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma |
| 30th Dec 2022 8:01 am |
EQS |
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics |
| 30th Dec 2022 7:01 am |
EQS |
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics |
| 12th Dec 2022 8:00 am |
EQS |
Unaudited NAV for November 2022 |
| 12th Dec 2022 7:01 am |
EQS |
Unaudited NAV for November 2022 |
| 6th Dec 2022 8:00 am |
EQS |
Arix to Present at Mello Investment Trusts & Funds |
| 6th Dec 2022 7:00 am |
EQS |
Arix to Present at Mello Investment Trusts & Funds |
| 1st Dec 2022 7:45 am |
RNS |
Director/PDMR Shareholding |
| 9th Nov 2022 8:00 am |
EQS |
Unaudited NAV for October 2022 |
| 9th Nov 2022 7:00 am |
EQS |
Unaudited NAV for October 2022 |
| 28th Oct 2022 7:00 am |
EQS |
Director/PDMR Shareholding |
| 28th Oct 2022 7:00 am |
EQS |
Director/PDMR Shareholding |
| 20th Oct 2022 4:30 pm |
EQS |
Holding(s) in Company |
| 20th Oct 2022 4:30 pm |
EQS |
Holding(s) in Company |
| 14th Oct 2022 7:00 am |
EQS |
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics |
| 14th Oct 2022 7:00 am |
EQS |
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics |
| 11th Oct 2022 7:00 am |
EQS |
Unaudited NAV for September 2022 |
| 11th Oct 2022 7:00 am |
EQS |
Unaudited NAV for September 2022 |
| 5th Oct 2022 7:00 am |
EQS |
Director/PDMR Shareholding |
